Today: 14 March 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Why D-Wave Quantum (QBTS) stock is slipping today as quantum IPO plans grab attention

Why D-Wave Quantum (QBTS) stock is slipping today as quantum IPO plans grab attention

D-Wave Quantum shares fell 0.5% to $29.99 Thursday afternoon, reversing gains from the previous session. Honeywell said Quantinuum plans to file a confidential S-1 for a potential IPO. D-Wave’s $550 million Quantum Circuits acquisition is expected to close by late January. Trading volume for D-Wave reached about 32 million shares.
15 January 2026
······
Coca-Cola stock dips today as Coke taps first chief digital officer ahead of earnings

Coca-Cola stock dips today as Coke taps first chief digital officer ahead of earnings

Coca-Cola shares fell about 1% Thursday after the company announced a leadership overhaul, including its first Chief Digital Officer and shifting commercial duties away from the CFO. The changes take effect March 31, as Henrique Braun prepares to succeed James Quincey as CEO. Investors await the Feb. 10 earnings report and Feb. 17 CAGNY presentation for more details on strategy. PepsiCo shares rose 0.6%.
15 January 2026
···
Circle stock (CRCL) slides as Senate stalls crypto bill, putting stablecoin rewards back in focus

Circle stock (CRCL) slides as Senate stalls crypto bill, putting stablecoin rewards back in focus

Circle shares fell 4.5% to $80.97 Thursday after a U.S. Senate panel delayed action on a crypto market-structure bill opposed by Coinbase. CEO Brian Armstrong warned the draft could end stablecoin rewards for customers. Crypto stocks broadly declined, with Coinbase down 3.2%. Investors are watching for signals ahead of the Federal Reserve’s January meeting.
15 January 2026
····
Marvell (MRVL) stock rises as RBC starts coverage, cites AWS Trainium and data-center demand

Marvell (MRVL) stock rises as RBC starts coverage, cites AWS Trainium and data-center demand

Marvell shares rose about 1% to $82.04 after RBC Capital Markets initiated coverage with an Outperform rating and $105 price target. The move followed TSMC’s strong earnings, which lifted chip stocks broadly. RBC cited firm orders from Amazon Web Services’ Trainium3 program and highlighted Marvell’s advances in photonics. Investors remain focused on sustained AI chip demand and Marvell’s upcoming earnings report.
15 January 2026
···
PepsiCo stock ticks up as UBS trims target and inflation keeps investors on edge

PepsiCo stock ticks up as UBS trims target and inflation keeps investors on edge

PepsiCo shares rose 0.6% to $146.80 in Thursday afternoon trading, building on Wednesday’s 1.7% gain. UBS cut its price target to $170 but kept a Buy rating, citing a tougher environment for staples. Investors are watching for early February earnings amid rising food inflation and concerns over pricing power. Siemens reported PepsiCo increased Gatorade plant throughput 20% using AI-powered digital twins.
15 January 2026
··
Booking Holdings stock steadies as U.S. visa move keeps travel names on edge (BKNG)

Booking Holdings stock steadies as U.S. visa move keeps travel names on edge (BKNG)

Booking Holdings shares were flat Thursday after a 2.4% drop Wednesday, as investors reacted to the U.S. suspension of immigrant visa processing for 75 countries starting Jan. 21. The move has pressured travel stocks and intensified scrutiny of U.S. entry policies ahead of the 2026 World Cup. Booking traded at $5,183.21 in the afternoon, about 11% below its 52-week high.
15 January 2026
····
Merck stock slips as FDA fast-track delays grab attention ahead of Feb. 3 earnings

Merck stock slips as FDA fast-track delays grab attention ahead of Feb. 3 earnings

Merck shares fell 0.2% to $110.75 Thursday after the FDA delayed decisions in its new voucher fast-track program, according to Reuters. The FDA postponed reviews of drugs from Sanofi, Disc Medicine, and Eli Lilly, citing safety concerns. Investors are watching for Merck’s Feb. 3 earnings and updates on its drug pipeline. Healthcare stocks broadly declined, with Eli Lilly down 3.6%.
15 January 2026
···
Amphenol (APH) stock jumps 6% as Goldman lifts target and company tees up ADC India open offer

Amphenol (APH) stock jumps 6% as Goldman lifts target and company tees up ADC India open offer

Amphenol shares jumped 6.4% to $156.13 after the company filed an open offer to buy 26% of ADC India, following its $10.5 billion CommScope deal. Goldman Sachs, BofA, and UBS raised price targets, citing strong data-center demand. The open offer totals about $16.4 million if fully accepted. Investors await Amphenol’s Jan. 28 earnings call for updates on integration and order trends.
15 January 2026
·
Bloom Energy stock jumps 8% as EIA flags data-center power surge

Bloom Energy stock jumps 8% as EIA flags data-center power surge

Bloom Energy shares jumped 8% to $144.11 Thursday, hitting a new intraday high amid investor focus on rising electricity demand from data centers. The move follows American Electric Power’s $2.65 billion deal to buy Bloom’s fuel cells for a Wyoming facility. Broader clean energy stocks also rose, while Bloom’s rivals fell. The EIA will release updated U.S. energy demand forecasts on February 10.
15 January 2026
···
ConocoPhillips stock slips in regular session as oil tumbles — what to watch before Feb. 5 earnings

ConocoPhillips stock slips in regular session as oil tumbles — what to watch before Feb. 5 earnings

ConocoPhillips shares fell 0.6% to $99.69 Thursday as crude prices dropped sharply, with Brent down 4.7% and WTI off 4.9% after U.S. comments eased Iran supply fears. The company reported early gas finds in Australia’s Otway Basin but has not committed to development. Investors await Feb. 5 results and 2026 guidance. Exxon Mobil, Chevron, and Occidental Petroleum also traded lower.
15 January 2026
····
Pfizer stock edges higher as vaccine-policy jitters and obesity race frame the next catalyst

Pfizer stock edges higher as vaccine-policy jitters and obesity race frame the next catalyst

Pfizer shares rose 0.3% to $25.67 Thursday as investors weighed U.S. vaccine policy debates and the company’s growth outlook. The stock moved between $25.26 and $25.67 with 22.3 million shares traded. Pfizer will report Q4 results on Feb. 3, with guidance projecting 2026 revenue of $59.5–$62.5 billion and lower COVID-19 product sales. Competition in obesity drugs and AI-driven drug discovery remain in focus.
15 January 2026
····
Morgan Stanley stock jumps as Wall Street deal talk returns after Q4 earnings

Morgan Stanley stock jumps as Wall Street deal talk returns after Q4 earnings

Morgan Stanley shares rose 5.9% to $191.41 after reporting fourth-quarter net revenues of $17.89 billion and earnings of $2.68 per share. Investment banking revenue reached $2.41 billion, and net new assets in wealth management totaled $122.3 billion. The board declared a $1.00 quarterly dividend and repurchased $1.5 billion in stock. Investors focused on rising deal activity and the upcoming Federal Reserve meeting.
15 January 2026
··
1 … 301 302 303 304 305 … 704

Stock Market Today

  • Gift Nifty Revolutionizes Pre-Market Analysis with Record Turnover in India
    March 14, 2026, 3:35 AM EDT. Gift Nifty has become a vital pre-market tool in India, hitting a record monthly turnover in 2025. This surge highlights its growing importance for investors and traders seeking early market direction. Integration with Foreign Institutional Investors (FII) and Domestic Institutional Investors (DII) flow data offers deeper insights. By tracking international market trends, Gift Nifty aids both institutional and retail investors in making data-driven decisions before trading hours begin. This marks a significant shift in the Indian financial sector towards technology-enabled, analytical trading strategies.
Go toTop